New Animal Drugs; Change of Sponsor's Address, 11120-11121 [05-4480]
Download as PDF
<![CDATA[
11120
Federal Register / Vol. 70, No. 44 / Tuesday, March 8, 2005 / Rules and Regulations
available to each date handler in
Riverside County.
(e) Each approved manufacturer of
date products is required to renew their
approved manufacturer status with the
committee by submitting an updated
CDAC Form No. 3 at the end of a crop
year, but no later than October 10 of the
new crop year. In addition, the
approved manufacturer must continue
to meet the other approved
manufacturer qualification
requirements.
(f) In the event an approved date
product manufacturer who is also a
regulated date handler within the area
of production does not remain in
compliance with the order, or fails or
refuses to submit reports or to pay
assessments required by the committee,
such date product manufacturer shall
become ineligible to continue as an
approved date product manufacturer.
Prior to making a determination to
remove a date product manufacturer
from the approved date product
manufacturer list, the committee shall
notify such manufacturer in writing of
its intention and the reasons for
removal. The committee shall allow the
date product manufacturer an
opportunity to respond. In the event
that a date product manufacturer’s name
has been removed from the list of
approved date product manufacturers, a
new application must be submitted to
the committee and the applicant must
await approval.
Dated: March 2, 2005.
Kenneth C. Clayton,
Acting Administrator, Agricultural Marketing
Service.
[FR Doc. 05–4448 Filed 3–7–05; 8:45 am]
BILLING CODE 3410–02–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
List of Subjects in 21 CFR Part 510
Food and Drug Administration
21 CFR Part 510
New Animal Drugs; Change of
Sponsor’s Address
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Final rule.
SUMMARY: The Food and Drug
Administration (FDA) is amending the
animal drug regulations to reflect a
change of sponsor’s address for
Wellmark International.
DATES: This rule is effective March 8,
2005.
FOR FURTHER INFORMATION CONTACT:
David R. Newkirk, Center for Veterinary
Medicine (HFV–100), Food and Drug
Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301–827–6967, email: david.newkirk@fda.gov.
SUPPLEMENTARY INFORMATION: Wellmark
International, 1100 East Woodfield Rd.,
suite 500, Schaumburg, IL 60173 has
informed FDA of a change of address to
1501 East Woodfield Rd., suite 200
West, Schaumburg, IL 60173.
*
*
*
Wellmark International, 1501
East Woodfield Rd., suite 200
West, Schaumburg, IL 60173
*
*
Administrative practice and
procedure, Animal drugs, Labeling,
Reporting and recordkeeping
requirements.
I Therefore, under the Federal Food,
Drug, and Cosmetic Act and under
authority delegated to the Commissioner
of Food and Drugs and redelegated to the
Center for Veterinary Medicine, 21 CFR
part 510 is amended as follows:
PART 510—NEW ANIMAL DRUGS
1. The authority citation for 21 CFR
part 510 continues to read as follows:
I
Authority: 21 U.S.C. 321, 331, 351, 352,
353, 360b, 371, 379e.
2. Section 510.600 is amended in the
table in paragraph (c)(1) by revising the
entry for ‘‘Wellmark International’’; and
in the table in paragraph (c)(2) by
revising the entry for ‘‘011536’’ to read
as follows:
I
§ 510.600 Names, addresses, and drug
labeler codes of sponsors of approved
applications.
*
*
*
(c) * * *
(1) * * *
Drug labeler
code
Firm name and address
*
Accordingly, the agency is amending
the regulations in 21 CFR 510.600(c) to
reflect the change.
This rule does not meet the definition
of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because
it is a rule of ‘‘particular applicability.’’
Therefore, it is not subject to the
congressional review requirements in 5
U.S.C. 801–808.
*
*
011536
*
*
(2) * * *
Drug labeler
code
*
Firm name and address
*
*
011536
*
VerDate jul<14>2003
11:16 Mar 07, 2005
Jkt 205001
PO 00000
Frm 00010
*
*
Wellmark International, 1501
East Woodfield Rd., suite 200
West, Schaumburg, IL 60173
*
Fmt 4700
*
Sfmt 4700
*
*
E:\FR\FM\08MRR1.SGM
08MRR1
*
*
Federal Register / Vol. 70, No. 44 / Tuesday, March 8, 2005 / Rules and Regulations
Dated: February 16, 2005.
Steven D. Vaughn,
Director, Office of New Animal Drug
Evaluation, Center for Veterinary Medicine.
[FR Doc. 05–4480 Filed 3–7–05; 8:45 am]
BILLING CODE 4160–01–S
§ 1.411(d)–4
11121
Authority: 26 U.S.C. 7805 * * *.
[Corrected]
Section 1.411(d)–4, A–2, paragraph
§ 1.409(p)–1T [Corrected]
(e)(3), Example (i) and (ii), in each
location the year ‘‘2004’’ is removed, and I Section 1.409(p)–1T(d)(2)(iv), is
removed.
the year ‘‘2005’’ is added in its place.
I
Cynthia E. Grigsby,
Acting Chief, Publications and Regulations
Branch, Legal Processing Division, Associate
Chief Counsel (Procedures and
Administration).
[FR Doc. 05–4502 Filed 3–7–05; 8:45 am]
Cynthia E. Grigsby,
Acting Chief, Publications and Regulations
Branch, Legal Processing Division, Associate
Chief Counsel (Procedures and
Administration).
[FR Doc. 05–4506 Filed 3–7–05; 8:45 am]
BILLING CODE 4830–01–P
BILLING CODE 4830–01–P
[TD 9176]
DEPARTMENT OF THE TREASURY
DEPARTMENT OF THE INTERIOR
RIN 1545–BC35
Internal Revenue Service
Office of Surface Mining Reclamation
and Enforcement
Elimination of Forms of Distribution in
Defined Contribution Plans; Correction
26 CFR Part 1
[TD 9164]
30 CFR Part 917
Internal Revenue Service (IRS),
Treasury.
ACTION: Correcting amendment.
RIN 1545–BC33
Kentucky Regulatory Program
Prohibited Allocations of Securities in
an S Corporation; Correction
AGENCY:
DEPARTMENT OF THE TREASURY
Internal Revenue Service
26 CFR Part 1
AGENCY:
SUMMARY: This document contains
corrections to (TD 9176), which were
published in the Federal Register on
Tuesday, January 25, 2005 (70 FR 3475).
These final regulations would modify
the circumstances under which certain
forms of distribution previously
available are permitted to be eliminated
from qualified defined contribution
plans.
This correction is effective
January 25, 2005.
DATES:
FOR FURTHER INFORMATION CONTACT:
Vernon S. Carter at (202) 622–6060 (not
a toll-free number).
SUPPLEMENTARY INFORMATION:
Background
The final regulations (TD 9176) that
are the subject of these corrections are
under section 411(d)(6) of the Internal
Revenue Code.
Need for Correction
As published, TD 9176 contains errors
that may prove to be misleading and are
in need of clarification.
List of Subjects in 26 CFR Part 1
Income taxes, Reporting and
recordkeeping requirements.
Correction of Publication
Accordingly, 26 CFR part 1 is corrected
by making the following correcting
amendments:
PART 1—INCOME TAXES
Paragraph 1. The authority citation for
part 1 continues to read in part as
follows:
Authority: 26 U.S.C. 7805 * * *.
VerDate jul<14>2003
11:16 Mar 07, 2005
Jkt 205001
SUMMARY: This document corrects
temporary regulations (TD 9164) that
were published in the Federal Register
on Friday, December 17, 2004 (69 FR
75455) concerning requirements for
employee stock ownership plans
(ESOPs) holding stock of Subchapter S
corporations.
DATES: This document is effective on
December 17, 2004.
FOR FURTHER INFORMATION CONTACT: John
T. Ricotta, (202) 622–6060 (not a tollfree number).
SUPPLEMENTARY INFORMATION:
Background
The temporary regulations (TD 9164)
that is the subject of this correction are
under section 409(p).
Need for Correction
As published, the temporary
regulations (TD 9164) contain errors that
may prove to be misleading and are in
need of clarification.
List of Subjects in 26 CFR Parts 1
Income Taxes, Reporting and
recordkeeping requirements.
I
I
Internal Revenue Service (IRS),
Treasury.
ACTION: Correcting amendment.
AGENCY:
Correction of Publication
Accordingly, 26 CFR part 1 is corrected
by making the following correcting
amendment:
I
PART 1—INCOME TAXES
Paragraph 1. The authority citation for
part 1 and continues to read in part as
follows:
I
PO 00000
Frm 00011
Fmt 4700
Sfmt 4700
Office of Surface Mining
Reclamation and Enforcement (OSM),
Interior.
ACTION: Final rule.
SUMMARY: This final rule removes a
suspension notation from our
regulations pertaining to the Kentucky
regulatory program (the ‘‘Kentucky
program’’). The suspension prohibited
the issuance of new financial guarantees
by the Kentucky Bond Pool because of
insufficient funds that had resulted from
the transfer of funds out of the bond
pool. Kentucky has reimbursed its bond
pool and the suspension notation
concerning that issue is being removed
because it is no longer necessary.
EFFECTIVE DATE: March 8, 2005.
FOR FURTHER INFORMATION CONTACT:
William J. Kovacic, Telephone: (859)
260–8400. Telefax number: (859) 260–
8410.
SUPPLEMENTARY INFORMATION:
I. Background on the Kentucky Program
II. Submission Information
III. OSM’s Findings
IV. Procedural Determinations
I. Background on the Kentucky
Program
Section 503(a) of the Act permits a
State to assume primacy for the
regulation of surface coal mining and
reclamation operations on non-Federal
and non-Indian lands within its borders
by demonstrating that its State program
includes, among other things, ‘‘a State
law which provides for the regulation of
surface coal mining and reclamation
operations in accordance with the
requirements of the Act * * *; and
rules and regulations consistent with
regulations issued by the Secretary
pursuant to the Act.’’ See 30 U.S.C.
E:\FR\FM\08MRR1.SGM
08MRR1
]]>Agencies
[Federal Register Volume 70, Number 44 (Tuesday, March 8, 2005)]
[Rules and Regulations]
[Pages 11120-11121]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-4480]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 510
New Animal Drugs; Change of Sponsor's Address
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect a change of sponsor's address for Wellmark
International.
DATES: This rule is effective March 8, 2005.
FOR FURTHER INFORMATION CONTACT: David R. Newkirk, Center for
Veterinary Medicine (HFV-100), Food and Drug Administration, 7500
Standish Pl., Rockville, MD 20855, 301-827-6967, e-mail:
david.newkirk@fda.gov.
SUPPLEMENTARY INFORMATION: Wellmark International, 1100 East Woodfield
Rd., suite 500, Schaumburg, IL 60173 has informed FDA of a change of
address to 1501 East Woodfield Rd., suite 200 West, Schaumburg, IL
60173. Accordingly, the agency is amending the regulations in 21 CFR
510.600(c) to reflect the change.
This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements
in 5 U.S.C. 801-808.
List of Subjects in 21 CFR Part 510
Administrative practice and procedure, Animal drugs, Labeling,
Reporting and recordkeeping requirements.
0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is
amended as follows:
PART 510--NEW ANIMAL DRUGS
0
1. The authority citation for 21 CFR part 510 continues to read as
follows:
Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.
0
2. Section 510.600 is amended in the table in paragraph (c)(1) by
revising the entry for ``Wellmark International''; and in the table in
paragraph (c)(2) by revising the entry for ``011536'' to read as
follows:
Sec. 510.600 Names, addresses, and drug labeler codes of sponsors of
approved applications.
* * * * *
(c) * * *
(1) * * *
------------------------------------------------------------------------
Firm name and address Drug labeler code
------------------------------------------------------------------------
* * * * *
------------------------------------------------------------------------
Wellmark International, 1501 East Woodfield 011536
Rd., suite 200 West, Schaumburg, IL 60173
------------------------------------------------------------------------
* * * * *
------------------------------------------------------------------------
(2) * * *
------------------------------------------------------------------------
Drug labeler code Firm name and address
------------------------------------------------------------------------
* * * * *
------------------------------------------------------------------------
011536 Wellmark International, 1501 East Woodfield
Rd., suite 200 West, Schaumburg, IL 60173
------------------------------------------------------------------------
* * * * *
------------------------------------------------------------------------
[[Page 11121]]
Dated: February 16, 2005.
Steven D. Vaughn,
Director, Office of New Animal Drug Evaluation, Center for Veterinary
Medicine.
[FR Doc. 05-4480 Filed 3-7-05; 8:45 am]
BILLING CODE 4160-01-S
